Pfizer PFE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:OtherShortTermInvestments.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pfizer's short-term investments?
- Pfizer (PFE) reported short-term investments of $11.37B in Q1 2026.
- How has Pfizer's short-term investments changed year-over-year?
- Pfizer's short-term investments decreased by 28.4% year-over-year, from $15.89B to $11.37B.
- What is the long-term trend for Pfizer's short-term investments?
- Over 5 years (2020 to 2025), Pfizer's short-term investments has grown at a 3.6% compound annual growth rate (CAGR), from $10.44B to $12.45B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.